Literature DB >> 21527804

Autoimmune haemolytic anaemia - a practical guide to cope with a diagnostic and therapeutic challenge.

S Zeerleder1.   

Abstract

Autoimmune haemolytic anaemia (AIHA) is a rare disease. In clinical practice, diagnosis and treatment of AIHA turns out to be troublesome. Correct diagnosis is dependent on proper comprehension of the pathophysiology and the laboratory tests performed by the transfusion laboratory. The present review provides a short overview on the pathogenesis of autoimmune haemolytic anaemia. The diagnostic pitfalls will be discussed and a diagnostic algorithm for proper diagnosis of AI HA will be given. Moreover, a brief overview on the treatment of different forms of AIHA is given.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527804

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  13 in total

1.  Methods for quantitative detection of antibody-induced complement activation on red blood cells.

Authors:  Elisabeth M Meulenbroek; Diana Wouters; Sacha Zeerleder
Journal:  J Vis Exp       Date:  2014-01-29       Impact factor: 1.355

2.  Neutrophil Erythrocyte Rosettes: An Unusual Manifestation of Autoimmune Hemolytic Anemia.

Authors:  Geeta Yadav; Khaliqur Rahman; Ruchi Gupta
Journal:  Indian J Hematol Blood Transfus       Date:  2015-05-05       Impact factor: 0.900

3.  Complement deposition in autoimmune hemolytic anemia is a footprint for difficult-to-detect IgM autoantibodies.

Authors:  Elisabeth M Meulenbroek; Masja de Haas; Conny Brouwer; Claudia Folman; Sacha S Zeerleder; Diana Wouters
Journal:  Haematologica       Date:  2015-09-09       Impact factor: 9.941

4.  Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine.

Authors:  Angela Corpolongo; Pasquale De Nardo; Piero Ghirga; Elisa Gentilotti; Rita Bellagamba; Chiara Tommasi; Maria Grazia Paglia; Emanuele Nicastri; Pasquale Narciso
Journal:  Malar J       Date:  2012-03-27       Impact factor: 2.979

5.  Thromboembolic complications in autoimmune hemolytic anemia: Retrospective study.

Authors:  Deborah Tabita Schär; Michael Daskalakis; Behrouz Mansouri; Alicia Rovo; Sacha Zeerleder
Journal:  Eur J Haematol       Date:  2021-10-24       Impact factor: 3.674

Review 6.  Complement inhibitors to treat IgM-mediated autoimmune hemolysis.

Authors:  Diana Wouters; Sacha Zeerleder
Journal:  Haematologica       Date:  2015-11       Impact factor: 9.941

Review 7.  Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.

Authors:  Sigbjørn Berentsen; Tatjana Sundic
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

Review 8.  Role of Complement in Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Transfus Med Hemother       Date:  2015-09-07       Impact factor: 3.747

9.  Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation.

Authors:  Myrthe E Sonneveld; Masja de Haas; Carolien Koeleman; Noortje de Haan; Sacha S Zeerleder; Peter C Ligthart; Manfred Wuhrer; C Ellen van der Schoot; Gestur Vidarsson
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

10.  Hepatic manifestations in hematological disorders.

Authors:  Jun Murakami; Yukihiro Shimizu
Journal:  Int J Hepatol       Date:  2013-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.